Home

Home

article image

Arterieal calcium scan predicts death risk

Scanning the heart’s arteries for calcium deposits might be one of the best ways to predict the overall risk of death for adults with cardiac trouble, a new study suggests. This might also help end the controversial discussions about calcium scans.

So-called calcium scans are controversial. It is a very expensive method sometimes promoted by for-profit centers. But a new study from the Habor-UCLA Medical Center published in the July issue of Journal of the American College of Cardiology might bring this discussion to an end.
 
Metthew Budoff, associate professor of medicine, and his colleagues found out that measuring the small calcium deposits of heart’s arteries can accuratly predict the patient’s death risk.
 
A calcium scan looks for calcification – or a hardening of the arteries caused by high blood fats and calcium deposits – in the arteries leading to and from the heart. These calcifications can block blood vessels and cause heart attacks, strokes or other health issues.
 
Previous studies already found coronary arterial calcium scans were effective tools for determining the overall death risk in young adults, diabetics, smokers and those suffering from renal failure. „But our investigation indicates coronary arterial scans are effective in measuring overall death risk in the elderly,“ Budoff said.
 
Researchers studied 35,383 adults, aged 40 to 80, in Torrance, CA and Nashville, TN, for an average of 5.8 years after having a coronary artery calcium scan. Among these research volunteers, 3,570 were age 70 or
older. In total, 838 deaths were recorded, 320 in women and 518 in men. The study found the overall death risk was higher among those with higher coronary arterial calcium scores. 
 
“This study provides additional validation of coronary calcium studies,” said Dr. Budoff. “Coronary arterial calcium scans can be very useful tools in assessing a patient’s overall death risk. With this information,
physicians can advise patients on diet, medications, exercise and other lifestyle changes that will help them avoid the risk of heart attack, strokes and other health problems.”
 
 
About LA Biomed:
 
Founded 56 years ago, LA BioMed is one of the country’s largest not-for-profit independent biomedical research institutes. It conducts biomedical research, trains young scientists and provides community
services, including childhood immunization, nutrition assistance and anti-gang violence programs. The institute’s researchers conduct studies in such areas as cardio-vascular disease, emerging infections,
cancer, diabetes, kidney disease, dermatology, reproductive health, vaccine development, respiratory disorders, inherited illnesses and neonatology.
 
LA BioMed is an independent institute that is academically affiliated with the David Geffen School of Medicine at UCLA. The institute is located on the campus of Harbor-UCLA Medical Center near Torrance.

 

Picture: Mayo Foundation for Medical Education and Research

This article was published on 07/31/2008

Search

 

Service

Company News

Meet us at MEDICA! Hall 7 Stand 15

The European Hospital team will be happy to hear about your research, products, R&D or trials and launches, hospital management issues, or any other aspects of your work, so that we can discuss your editorial ideas. We will also be pleased to help with any PR or advertising queries.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.